|
Market Cap (5-Jun) $4,960,185 (1,007th) |
Close (30-Jun) $0.038 |
Volume (30-Jun) 1,963,571 |
Shortsold (11-May) 1 (0.00%) (717th) |
|
52w High $0.60 |
52w Low $0.083 |
P/E - |
EPS -0.84 |
CHM released this announcement to the ASX on 8 March 2022, 11:53. The announcement is not marked as price sensitive, and is 55 page(s) in length and 864.35kb in size.
You can view all announcements from CHM and see how they appear on a price chart on the announcements page.
At the date of this announcement, CHM was 0.029% short sold according to ASIC data. It was ranked the 594th most shorted stock on the ASX. It remains ranked 717th as of the latest reported data (11 May 2026).
| Other Recent Announcements from CHM | |
|---|---|
| Notice under section 708A | 29 June 2023, 15:34 |
| Application for quotation of securities - CHM | 29 June 2023, 15:29 |
| Results of Extraordinary General Meeting | 29 June 2023, 11:42 |
| Appendix 3B (amended) | 8 March 2022, 11:53 |
| Extension of Closing Date for Retail Entitlement Offer | 8 March 2022, 11:37 |
| Final Results in Phase 1 Trial of CORE NK Platform | 7 March 2022, 10:16 |
| CORE NK Platform Phase 1 Clinical Data Presentation | 7 March 2022, 9:01 |
You must be logged in to post a reply.
Chimeric Therapeutics Ltd 